Skip to main content

Research Repository

Advanced Search

Kaleidoscope - Volume 221 , Issue 5

Tracy, Derek K.; Joyce, Dan W.; Albertson, Dawn N.; Shergill, Sukhwinder S.

Authors

Derek K. Tracy

Dan W. Joyce

Dawn N. Albertson

Sukhwinder S. Shergill



Abstract

Medication non-serious adverse events (NSAEs) are common yet frequently overlooked in the scientific literature. Chevance et alReference Chevance, Tomlinson, Ravaud, Touboul, Henshall and Tran1 conducted an international survey of patients and clinicians (available in English, French and German) to identify the most important antidepressant NSAEs. Overall, this included 1631 patients with severe depression (four-fifths of whom were women) and 281 healthcare professionals (HCPs, four-fifths of whom were psychiatrists) from 44 countries. The most important NSAEs for patients, in order of frequency, were deemed to be insomnia, anxiety, fatigue, weight gain, agitation and sexual dysfunction. There was considerable heterogeneity insofar as no NSAE was selected as being in the top three by more than a quarter of participants, with the sole exception of insomnia. Interestingly, neither depression severity nor whether one was taking medication at the time had any impact on rankings. For HCPs, the order was: sexual dysfunction, weight gain, erectile disorders, sleepiness, agitation and nausea. Further clinically important issues included emotional numbing and problems with concentration. Of course, survey data always come with significant caveats, not least via the issue of potential selection bias. Nevertheless, the authors note that discussions with those in real-world clinical settings should occur more often and call for more systematic collection of these ‘less severe’ but very real and common problems. Research trials need to pay more attention to these important factors.

Citation

Tracy, D. K., Joyce, D. W., Albertson, D. N., & Shergill, S. S. (2022). Kaleidoscope - Volume 221 , Issue 5. British Journal of Psychiatry, 221(5), 709-710. https://doi.org/10.1192/bjp.2022.137

Journal Article Type Editorial
Acceptance Date Nov 1, 2022
Online Publication Date Oct 24, 2022
Publication Date Nov 1, 2022
Deposit Date Jun 21, 2023
Journal British Journal of Psychiatry
Print ISSN 0007-1250
Electronic ISSN 1472-1465
Publisher Cambridge University Press (CUP)
Peer Reviewed Not Peer Reviewed
Volume 221
Issue 5
Pages 709-710
DOI https://doi.org/10.1192/bjp.2022.137
Public URL https://uwe-repository.worktribe.com/output/10881029
Publisher URL https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/kaleidoscope/2CBA319D67F4F25C375C48CF7F709D8E


You might also like



Downloadable Citations